SORL [SORL Auto Parts] 15-12G:
[]
[] [I, Sheng Fu, certify that: 20-F 1. I have reviewed this Amendment No. 1 to the annual report on Form 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances]
[001-31914 ANNOUNCEMENT APPROVAL OF QUALIFICATION OF PERSON IN CHARGE OF FINANCE BY CBIRC BEIJING BUREAU Company Reference is made to the announcement of China Life Insurance Company Limited (the CBIRC Beijing Bureau Please refer to the announcement of the Company dated 23 April 2020 for the biogra]
[] [Summary In accord with Rule 13p-1, Himax undertook due diligence to seek to determine whether the necessary conflict minerals in the products placed into commerce by Himax were or were not “DRC Conflict Free”. Himax designed its due diligence measures to be in conformity, in all material respects]
[Alibaba Group Announces March Quarter and Full Fiscal Year 2020 Results Hangzhou, China, May 22, 2020 Alibaba achieved the historic milestone of US$1 trillion in GMV across our digital economy this fiscal year, said Daniel Zhang, Chairman and Chief Executive Officer of Alibaba Group. Our overall ]
[中國海洋石油有限公司 CNOOC LIMITED CNOOC Limited Announces Penglai 19-3 Oilfield Area 4 adjustment/Penglai 19-9 Oilfield Phase II Project Commences Production (Hong Kong, May 22, 2020) - CNOOC Limited (the “Company”, SEHK: 00883, NYSE: CEO, TSX: CNU) announced today that Penglai 19-3 oilfield area 4 adjustmen]
[EMPLOYMENT AGREEMENT Agreement Effective Date Company Executive This EMPLOYMENT AGREEMENT (the “ WITNESSETH: WHEREAS NOW, THEREFORE EMPLOYMENT 1. Agreement to Employ 1.1 Duties and Schedule Board 1.2 TERM OF EMPLOYMENT Term 2. COMPENSATION 3. Salary Salary 3.1 Vacation 3.2 Business Expenses 3.3 Bene]
[Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development BEIJING, May 22, 2020 -- (BUSINESS WIRE) -- Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech C]